ciprofloxacin has been researched along with paraquat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dean, CR; Möker, N; Tao, J | 1 |
Hidalgo, AA; Millanao, AR; Mora, AY; Mora, GC; Saavedra, CP; Valenzuela, LM; Villagra, NA | 1 |
2 other study(ies) available for ciprofloxacin and paraquat
Article | Year |
---|---|
Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules.
Topics: Acyl-Butyrolactones; Anti-Bacterial Agents; Bacterial Proteins; Carbenicillin; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Gene Deletion; Genetic Complementation Test; Humans; Microbial Viability; Paraquat; Pseudomonas aeruginosa; Pyocyanine; Quorum Sensing; Signal Transduction; Stress, Physiological | 2010 |
Cysteine auxotrophy drives reduced susceptibility to quinolones and paraquat by inducing the expression of efflux-pump systems and detoxifying enzymes in S. Typhimurium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cysteine; Drug Resistance, Multiple, Bacterial; Gene Deletion; Gene Expression; Genes, Bacterial; Humans; Levofloxacin; Membrane Transport Proteins; Mutation; Nalidixic Acid; Paraquat; Quinolones; Reactive Oxygen Species; Salmonella typhimurium; Sulfur | 2019 |